Transmissible spongiform encephalopathies (TSEs), otherwise known as prion disorders, are fatal diseases causing neurodegeneration in a wide range of mammalian hosts, including humans. The causative agentsprions -are thought to be composed of a rogue isoform of the endogenous prion protein (PrP). Beyond these and other basic concepts, fundamental questions in prion biology remain unanswered, such as the physiological function of PrP, the molecular mechanisms underlying prion pathogenesis, and the origin of prions. To date, the occurrence of TSEs in lower vertebrates like fish and birds has received only limited attention, despite the fact that these animals possess bona fide PrPs. Recent findings, however, have brought fish before the footlights of prion research. Fish models are beginning to provide useful insights into the roles of PrP in health and disease, as well as the potential risk of prion transmission between fish and mammals. Although still in its infancy, the use of fish models in TSE research could significantly improve our basic understanding of prion diseases, and also help anticipate risks to public health. This article is part of a Special Issue entitled Zebrafish Models of Neurological Diseases.
1. Introduction
Prion disorders
Prion diseases or TSEs are a group of rare but fatal neurological disorders that affect humans and animals. Whether sporadic, inherited or acquired, these illnesses generally correlate with the accumulation of misfolded PrP in the brain and the appearance of widespread neurodegeneration after long incubation times [1] . The classical histopathological landmarks of TSEs are spongiform vacuolation, neuronal loss and astrocytic gliosis, whereas the main clinical manifestations in humans include progressive dementia, cerebellar ataxia and myoclonus [2] . Interestingly, although such symptoms are also observed in more common neurodegenerative disorders like Alzheimer's disease (AD) and Parkinson's disease (PD), prion diseases have received special attention because of their infectious nature and the associated risk of epidemics.
In fact, prion diseases gained considerable notoriety in the 1990s because of the massive outbreak of mad cow disease (bovine spongiform encephalopathy, BSE) in Europe and the negative impact it had on public health and the food industry. TSEs are, however, not a recent phenomenon. Their history dates back to the 1700s when scrapie, a related neurological condition among sheep and goats, was first described in England [3] . Other TSEs in animals include chronic wasting disease (CWD) in deer and elk, transmissible mink encephalopathy and feline spongiform encephalopathy (FSE) [4] . The most common TSEs in humans, Creutzfeldt-Jacob disease (CJD) and Gerstmann Sträussler Scheinker syndrome (GSS), were discovered much later (1920s and 1930s, respectively [5] ), and it was not until the 1950s that the study of kuru, another human prion disease, set off a chain of revolutionary discoveries that would redefine the meaning of "pathogen" and push a biological dogma against the ropes.
The nature of the infectious TSE agent
Kuru was originally described as a neurological epidemic of the Fore linguistic group in Papua New Guinea [2] . For some time, the disease was believed to be infectious, and possibly transmitted during cannibalistic rituals. Nevertheless, failure to transmit kuru to laboratory animals led to the erroneous assumption that it had a genetic basis. Towards 1959, remarkable similarities between kuru, CJD and scrapie were recognized at the neuropathological, clinical and epidemiological levels [6, 7] . Since scrapie had been already shown to be transmissible [8] , it became apparent that kuru and CJD were also of infectious etiology. Indeed, by 1968, both human diseases had been successfully transmitted to chimpanzees [9, 10] . Despite these advances, the nature of the scrapie agent continued to be the subject of intense debate for many years. Because TSEs exhibit strain variation and long incubation periods, it was argued that the agent could be a slow-virus [11] . However, direct proof for this "viral hypothesis" has been difficult to obtain [12] . Instead, it has been shown that the transmissible agent is resistant to formalin (a chemical that inactivates viruses) and to various other treatments that destroy nucleic acids, but not to proteolytic digestion [13] [14] [15] . These and other developments finally led to the enunciation of the "protein-only hypothesis" by Stanley Prusiner (1982) , according to which TSEs are caused by prions, small proteinaceous particles capable of replicating in the absence of nucleic acids [14, 16] .
The protein-only hypothesis has not remained uncontested. While some continue to advocate the existence of an unidentified scrapie agent [17] [18] [19] , others see the notion of an infectious, self-replicating protein as a clear violation of Crick's central dogma of molecular biology [20] , which excludes the flow of biological information from protein to protein. Notwithstanding the controversy, Prusiner's theory reasonably accounts for the complex etiology of TSEs, the physicochemical properties of the agent, and the existence of scrapie strains [3] . Today, it is widely accepted that prions are largely -if not entirely -composed of PrP Sc , an abnormally folded isoform of the cellular prion protein (PrP C ) [21] . The molecular mechanism by which normal PrP C "converts"
into infectious PrP Sc is, however, poorly understood. It has been proposed that PrP Sc can associate with PrP C and induce its conversion into more PrP Sc , triggering a chain reaction [22] . Alternatively, PrP Sc and PrP C may coexist in equilibrium until mutation or sporadic events favor the formation of oligomeric PrP Sc seeds, which undergo repeated aggregation and fragmentation cycles [23] . In either case, the concept of PrP conversion is central to the protein-only hypothesis because it explains the ability of prions to replicate and propagate disease.
The prion protein
In 1982, PrP Sc was identified as the major constituent of infective fractions purified from hamster brain homogenates [24] . Subsequent characterization revealed that the pathogenic protein was host-encoded and not the product of a viral gene, as it had been assumed previously [25, 26] . It was also established that PrP Sc is posttranslationally derived from PrP C [27] . Thus, although the two isoforms differ greatly in their spatial conformation [28] , they have the same amino acid sequence and are encoded by the same single-copy gene, Prnp [29] . Under normal conditions, PrP C is a glycoprotein tethered to the outer plasma membrane by a glycosylphosphatidylinositol (GPI) anchor. Its unique molecular structure, studied by nuclear magnetic resonance (NMR) and crystallographic techniques, can be roughly divided into two halves: a flexible N-terminal domain rich in repetitive motifs, and a C-terminal globular domain containing a characteristic array of three α-helices and two β-sheets. At the center of the polypeptide chain, a short hydrophobic stretch connects the two major domains [30, 31] . In contrast, attempts to resolve the molecular structure of PrP Sc have not been successful. Almost 30 years after the discovery of PrP, there is still no consensus about what its physiological role might be. Since PrP has no obvious similarities to known protein families, functional affinities cannot be inferred from amino acid sequence comparisons. Neither can organ-or tissue-specific functions be hypothesized because PrP is widely expressed in most adult and embryonic cell types [32] [33] [34] [35] . Astonishingly, the generation and analysis of PrP knockout mice failed to provide conclusive information about the physiological role of PrP, as these animals develop and behave rather normally. Aside from a few subtle abnormalities, their only clear "phenotype" is their resistance to prion infection [36] . It is probably not exaggerated to say that as many PrP functions have been proposed as methods have been employed to address this question. Thus, the list of putative PrP roles in vitro and in vivo includes activities as diverse as cytoprotection from apoptosis [37] and oxidative stress [38] , olfactory behavior [39] , copper metabolism [40] , neurogenesis [41] , neurite outgrowth and neuronal survival [42] , lymphocyte activation [43] , hematopoietic stem cell self-renewal [44] , synaptic function [45] , activation of signal transduction [46] , and binding to cell adhesion molecules [47] . Unfortunately, it is not clear how many of these findings may be of actual physiological relevance. In addition, it seems unlikely that a single molecular function of PrP could account for such diverse biological roles.
The clear correlation between PrP misfolding and neurodegeneration may suggest that PrP Sc is the direct cause of prion disease.
Nevertheless, solid experimental evidence indicates that prions cannot induce neuronal damage in the absence of PrP C . For instance, PrP knockout mice are resistant to scrapie inoculation [48] , even if they carry PrP C -expressing neurografts [49] , or if PrP C depletion is induced postnatally [50] . Notably, transgenic mice expressing only a GPI-anchorless version of PrP (thus unable to attach to the plasma membrane) can efficiently replicate prions without developing prion disease [51] . Altogether, these studies demonstrate that prion neurotoxicity is not triggered by PrP Sc itself, but by an activity of PrP C at the cell surface. Accordingly, it has been proposed that prion replication might cause PrP C to either lose a neuroprotective role, gain a neurotoxic one, or subvert a neuroprotective role into a neurotoxic one [52] . Therefore, a thorough characterization of PrP C function will likely be instrumental in ascertaining the molecular basis of prioninduced neurodegeneration.
Open challenges in prion biology and pathogenesis
The past five decades have seen remarkable achievements that shaped our current understanding of TSEs. These include the transmissibility of kuru and CJD to laboratory animals, the isolation of the scrapie agent, the development of the protein-only hypothesis, the identification of PrP and its isoforms, and the study of prion propagation in genetically modified mice. Yet, very little has been learned about basic aspects of prion pathogenesis, such as the mechanisms of PrP misfolding and prion replication, the physiological function of PrP, or the cellular pathways through which prions induce neurodegeneration. To this day, prion disorders remain incurable, and neither early diagnostic methods nor anti-prion drugs have successfully been developed. Of special concern is the possibility that animal prion diseases may be transmitted to humans via the food chain. In fact, experimental evidence indicates that transmission of BSE to humans was the likeliest cause for the appearance of a new variant form of CJD (vCJD) [53, 54] . These findings illustrate the need to ensure food safety, not only through efficient quality control but also by experimentally assessing the risk of prion transmission across a wide range of animal hosts.
So far, only beef and lamb have been identified as potential sources of dietary prion infections. Other major animal food sources like fish and poultry appear to have remained free of prion contamination. However, it is not clear whether these organisms are susceptible to prion pathogenesis because TSE research has been carried out predominantly in mice and other mammals. Therefore, the study of prion biology in non-mammals, particularly in fish, is of great relevance to food safety. Fish constitute a vital food resource for humans and animals worldwide (Table 1) , with direct impact on important economic activities like fishing and aquaculture.
In addition, several fish species have become valuable tools in biomedical research. One of them, the zebrafish (Danio rerio), is an excellent model to study vertebrate development and the biology of human disease. It has many advantages as a genetic system, such as its large offspring size and short generation time [55] . Furthermore, zebrafish embryos are transparent and develop externally, making them amenable to detailed cellular analyses and genetic manipulations. Moreover, the zebrafish is rapidly emerging as a valuable tool in clinical and pharmaceutical research aimed at drug discovery and validation [56, 57] .
In this article, we review current knowledge about the occurrence of PrPs, prions, and TSEs among vertebrates, focusing on recent advances using fish models to characterize the physiological function of PrP and the possible risk of prion transmission between fish and mammals.
Prion disease: a mammalian attribute?
2.1. PrP and prion-like "behavior"
Besides PrP, a handful of mammalian proteins appear to be able to replicate in a prion-like manner. Among them are the molecular culprits of known neurodegenerative disorders, such as amyloid-β (Alzheimer's disease), α-synuclein (Parkinson's disease), tau (Tauopathies) and amyloid A (AA amyloidosis) [58] . Such observations are undoubtedly intriguing, yet it still needs to be established whether the rogue versions of these proteins are indeed infectious and, like bona fide prions, capable of spreading disease between individuals or even across species. In fungi, at least six different proteins exhibit prion-like behavior, as judged by their ability to propagate phenotypic traits between cells without the need for nucleic acids [59] . However, these proteins have neither structural nor functional similarities to PrP, or to one another. Thus, while the study of fungal prions has provided valuable information about the molecular basis of prion conversion, it is not clear to what extent this knowledge may apply to mammalian prion disease [60] .
In addition to mammals, PrP homologues have also been identified in birds [61] , reptiles [62] , amphibians [63] and fish [64] , but not in invertebrates. Comparison of amino acid sequences indicates that PrPs have evolved differently in each vertebrate class. For instance, although mammalian and avian sequences are strongly conserved, with similarity scores of~90% in each group, conservation between the two groups is rather low (~30% similarity) [65, 66] . Likewise, PrP sequences among bony fish are relatively well conserved (50-60% similarity), but exhibit only 20-25% similarity to mammalian sequences [67] . PrPs also exhibit considerable variation in size, ranging from~260 amino acids in mammals and birds to~600 amino acids in fish. Despite these large differences in length and sequence, all vertebrate PrPs share the same protein domains (Fig. 1) [67, 68] . The degree of conservation varies significantly along the polypeptide, with the short hydrophobic stretch and the repetitive domain being the most conserved and the most divergent regions of the protein, respectively. Remarkably, and despite having undergone substantial sequence variation, the globular domain retained its structural fold throughout evolution [67, 69] . These observations strongly suggest that the globular domain carries out an important function, which was already present in the last common ancestor of all vertebrates. Whether prion behavior was already an intrinsic attribute of such primitive PrPs, or whether it appeared late in evolution remains to be clarified.
So far, TSEs have only been reported in mammals. This is not surprising, since prion biology is a field primarily focused on the study of human diseases. Nevertheless, if PrP is intrinsically able to form infectious prions, then its presence in non-mammals implies that these animals would -at least in theory -be susceptible to some form of prion disease. Evaluating this scenario is particularly difficult without basic knowledge about PrP conversion and prion replication in nonmammalian species. Moreover, it is not even clear what the eventual manifestations of TSEs in fish or birds might be. Clearly, extensive experimentation will be required to establish whether these organisms can acquire and transmit prion disease.
Prion transmission and the species barrier
Prion transmission across different species is limited by the so-called species barrier. Following primary inoculation between two species, only some animals develop disease, with long incubation periods that may reach the normal life span of the species. This phenomenon is clearly illustrated by the resistance to TSE observed in rabbits, even after intracranial inoculation with TSE agents of sheep, mouse and human origin [70] . It has been suggested that the unique structural characteristics of rabbit PrP make it less prone to pathogenic conversion [70, 71] . Typically, species barriers become attenuated after serial passaging of a prion strain, resulting in shortened incubation times and the consequent adaptation of the host to the specific strain [72] . At the molecular level, the efficiency of interspecies prion transmission appears to depend on the degree of sequence and structural identity between the PrPs of the two species involved [73] . For instance, wild type mice do not become infected with hamster prions, whereas transgenic mice overexpressing hamster PrP do [74] . However, BSE can effectively be transmitted to a wide range of species and maintain its pathogenic characteristics, even when passaged through an intermediate species carrying a different PrP coding gene [75] .
It has been proposed that every species harbors a number of possible PrP Sc conformational variants, with a thermodynamically "preferred" conformation (strain) being the decisive factor for interspecies transmission. According to this "conformational selection model" [76] , a significant overlap between the preferred PrP Sc configurations of two species is likely to result in a relatively easy transmission of prions between them [77] . On the contrary, two species not sharing common PrP Sc structures would have to overcome a considerable barrier to transmission, and pathogenesis would not ensue without modification of the strain type. Therefore, evaluation of the prion transmission from one species to another should also be based on the structural identity between the host and donor PrP molecules and not exclusively on their amino acid sequence [78] . The route of infection is another parameter affecting the magnitude of species barriers. Most inoculation studies rely on the use of intracranial injection because "natural" per os infection is usually less effective [79, 80] . Notably, even after homologous oral transmission of BSE to cattle, animals may remain presymptomatic for 28 months, despite the evident PrP Sc deposition in their brains [81] . Although the relative importance of the aforementioned factors has been extensively studied, the outcome of an intra-species prion transmission cannot be predicted in advance. It is noteworthy, that two different TSE strains that can effectively infect one species may present completely modified transmissibility potentials when transmitted to a second species. Thus, it has been proposed that a more suitable term to describe these Mediterranean countries Europe phenomena would be "transmission barriers" instead of "species barriers" [76] . Recent data have led to the reconsideration of many parameters that were thought to be indicative of a species barrier, such as the lack of clinical symptoms. Interestingly, cases of subclinical infection in mammals displaying neuropathological and biochemical abnormalities, often including PrP Sc accumulation, have been reported [82] . Thus, prion-inoculated animals harboring high infectivity levels, and even abnormal PrP aggregates in their brains, may under certain circumstances remain asymptomatic carriers throughout their lifetime. Notably, subclinical disease has been reported even after homologous transmission, for instance, in studies using the oral route of infection and low dosage inoculum [79, 83, 84] .
Fish prion proteins

Duplicated PrPs in bony fish
PrP genes from land vertebrates have typically been cloned using conventional procedures such as cDNA hybridization and PCR screening. In contrast, fish PrP genes could not be isolated with these methods due to their large DNA sequence divergence. The first fish PrP homologue was identified in Fugu rubripes by searching genome databases for ORFs encoding key structural features of PrPs [64] . Subsequent cloning and sequencing of PrP genes in salmon, trout, carp, stickleback, sea bream and zebrafish [67, 68, 85, 86] revealed that bony fish possess two PrP orthologs, PrP-1 and PrP-2, which probably arose during a fish-specific genome duplication [87] . Northern and Western Blot analyses indicated that the fish proteins are expressed at particularly high levels in adult fish brains, as well as in muscle, skin, heart and gills [67] . Although quite variable in size and sequence, PrP-1 and PrP-2 present characteristic features of mammalian PrPs: an Nterminal signal peptide, conserved N-glycosylation sites, two cysteine residues that form a disulphide bond, a central hydrophobic stretch, and the C-terminal signal for the attachment of a GPI-anchor (Fig. 1 ). An intriguing feature of fish PrPs is the presence of a highly conserved motif of 13 amino acids in length between the repetitive region and the hydrophobic stretch [67] ; the structural or functional importance of this motif is not evident from its sequence.
The repetitive domains of fish PrPs are easily recognizable but at the same time clearly different from those of tetrapod PrPs. For example, while a constant number of nearly identical octarepeats is typical for mammals (or hexarepeats in birds), in fish the number and length of degenerate repeats vary from species to species. Nevertheless, all PrP repeats can be considered variations of two basic types of repeats (A and B), which evolved differentially in every vertebrate class [67] . The sequence of the globular domain also has diverged considerably between fish and mammals, owing to high rates of amino acid substitutions, insertions and deletions. Notably, these changes predominantly affect residues outside key structural motifs, and are not expected to affect the globular fold [67] .
Apart from PrP-1 and PrP-2, other genes partially resembling PrP have been reported in fish. Originally described as PrP-like and Shadoo [88, 89] , they are also known as PrP-1-rel and PrP-2-rel because of their genomic location, directly downstream of PrP-1 and PrP-2, respectively [67] . The encoded products are GPI-anchored polypeptides of only 150-180 amino acids in length, expressed in brain tissues, and containing the characteristic PrP hydrophobic stretch. Further similarities to PrPs include a β-strand motif in PrP-rel-1 identical to the first β-strand of PrP, and the presence of degenerated B-and Alike repeats in PrP-rel-2. This situation is reminiscent to that of Prnp and its genomic neighbor Doppel. Thus, PrP-rels, like Doppel, may have arisen from the tandem duplication of an ancestral PrP gene, and then diverged as a result of high substitution rates and the differential loss of motifs. Interestingly, although PrP-rels are predicted to be unstructured proteins, their mammalian homologue Shadoo has recently received attention because it appears to influence biological and pathogenic activities of PrP in vivo [90, 91] .
Zebrafish PrP-1 and PrP-2
The characterization of PrP homologues in the zebrafish opened the exciting possibility to study prion biology in a new model organism. Like other bony fish, the zebrafish has two prion protein orthologs, PrP-1 and PrP-2, mapped to chromosomes 10 and 25, respectively [67] . Genomic studies revealed that the two genes originated from the duplication of a large chromosomal block that corresponds to those containing the Prnp gene in mammals. That both gene copies are fully functional has been biochemically confirmed in fish and mammalian cells [92, 93] . In these studies, it was shown that the encoded polypeptides become properly glycosylated and attached to the plasma membrane via a GPI-anchor. As is often the case with duplicated genes [94] , PrP-1 and PrP-2 are thought to have retained complementary subsets of ancestral PrP functions. Accordingly, zebrafish PrPs have evolved distinct spatiotemporal patterns of embryonic expression: while PrP-1 is ubiquitously expressed at high levels in very early stages of embryogenesis (blastula and gastrula stages), PrP-2 is strongly upregulated at later stages in developing neurons [92] . At later larval stages and into adulthood, both genes continue to be expressed in the CNS, although PrP-2 at much higher levels than PrP-1. The differences between the expression patterns of PrP-1 and PrP-2 are due to the divergent evolution of DNA transcriptional regulatory sequences upstream of each gene (Barth and Málaga-Trillo, unpublished data). Interestingly, the expression of zebrafish PrPs (particularly PrP-2) in the developing nervous system bears striking similarities to that of PrP in the mouse embryo [32] . It remains to be determined if, like PrP-1, mammalian PrP plays a role during blastula and early gastrula stages.
PrP loss of function phenotypes in zebrafish embryos
One of the many experimental advantages of the zebrafish is the possibility to knockdown the expression of any given gene using morpholino antisense oligonucleotides. When microinjected into early fish embryos, morpholinos rapidly bind to their target mRNAs and block their translation [95] . Recently, this method was successfully applied to study PrP loss of function in the zebrafish. In contrast to the absence of clear phenotypes in PrP knockout mice, knockdown of zebrafish PrPs revealed that these genes play essential roles during distinct phases of embryonic development. Specifically, PrP-1 knockdown causes lethal embryonic arrest during gastrulation, whereas PrP-2 knockdown severely impairs brain development. Notably, the PrP-1 phenotype can be rescued by PrP-1 or PrP-2 overexpression, indicating that although the two proteins are expressed in different developmental contexts, they share essentially the same biological activity. Furthermore, the ability of mouse PrP to partially revert the PrP-1 phenotype strongly suggests that this activity of PrP is conserved between fish and mammals [92] . It is therefore surprising that the loss of such an important function would not be evident in PrP knockout mice, especially since PrP is expressed at high levels in the mouse embryo. A plausible explanation for this discrepancy is that the mouse knockout phenotype may become masked by genetic compensation or developmental plasticity [96] .
The relative simplicity of the zebrafish gastrula makes the PrP-1 phenotype an excellent choice to analyze conserved mechanisms of PrP function at the molecular and cellular levels. Detailed characterization of PrP-1 knockdown embryos revealed that the developmental arrest was caused by the loss of tissue cohesion and the consequent failure to carry out epiboly, an early morphogenetic cell movement. Because epiboly relies on the control of cell-cell adhesion, this finding led to the discovery that PrP-1 regulates the stability of E-cadherin/ß-catenin adhesive complexes at the plasma membrane [92] . Ongoing biochemical work indicates that the mechanism behind this effect is the ability of PrP-1 to control the levels and membrane localization of ß-catenin as well as the levels and phosphorylation state of Srcrelated kinases (Sempou and Málaga-Trillo, in preparation). Related unpublished in vivo pharmacological data suggest that PrP-1 acts to prevent the degradation of some of these proteins.
These results are in agreement with long proposed roles of PrP as a signal transduction molecule [46] . Concretely, the experiments with zebrafish gastrulae indicate that a complex signaling cascade is initiated by the interaction between PrP-1 molecules across opposite cell membranes. Accordingly, in vitro experiments show that fish, amphibian, avian and mammalian PrPs share the intrinsic ability to engage in such homophilic trans-interactions, promoting the formation of cell-cell contacts, and triggering intracellular signaling via Srcrelated kinases [92] . Of special interest within the scope of this review is the finding of heterologous interactions between zebrafish and mammalian PrPs [92] , which raise the question of whether PrP conversion and TSE transmission can take place across such distant species.
Altogether, the combined work in zebrafish embryos and mammalian cells indicate that PrPs play crucial roles in cell-cell communication (Fig. 1) . These data are in line with the notion that PrP provides protective signals required for neuronal growth and/or survival [97, 98] . Understanding the precise nature of such signals will be crucial to uncover the early cellular mechanisms of prion pathogenesis in the mammalian brain.
Risk of prion disease in fish
TSEs and the food chain
The appearance of BSE in Europe has been causally linked to the common practice of feeding cattle with meat and bone meal (MBM) of bovine origin [99] . Approximately 200,000 BSE cases were reported between 1985 and 2000, and it has been estimated that roughly three million infected animals could have entered the human food chain before developing a clinical disease [81] . Due to its low cost and high nutritional value, MBM has become an important ingredient in the diet of non-ruminant livestock and farmed fish. Hence, there is the theoretical risk that farmed animals unintentionally fed with prioncontaminated MBM might develop TSEs or serve as asymptomatic carriers of a disease [100] . Since BSE was initially reported, the European Commission (EC) has implemented a comprehensive set of TSE risk-reducing measures to protect humans from BSE, as well as to control and eventually eradicate prion diseases in animals. Among these, a total EU-wide feed ban on the use of rendered animal proteins in the nutrition of all animals was imposed, with minor exceptions (i.e. use of fish feeds in the diets of non-ruminants like pigs and chicken).
Experimental demonstration that TSEs can propagate in a new host without typical pathognomonic brain lesions, clinical disease or fatality, has led to the conclusion that prion-infected individuals could go undetected within an exposed population [100] . This implies that farmed animals may carry the disease but not develop it until they are slaughtered. Human consumption of meat from these animals would, in turn, give rise to repeated infection cycles long before clinical signs can be recognized. Moreover, the relatively recent discovery of unconventional TSE phenotypes, such as atypical scrapie in sheep and goats [101, 102] , and bovine amyloidotic spongiform encephalopathy (BASE) in cattle [103] , usually displaying decreased or altered PrP Sc resistance to proteolytic treatment and less pronounced clinical signs, has further made it difficult to define prion diseases in absolute terms and thus, to implement effective rules to eliminate them.
Risk of prion transmission to fish
According to the aforementioned arguments, fish, poultry and pigs represent potential candidate hosts for prion infection. In order to assess the risk of prion transmission to fish, five main parameters should be considered: 1. the potential use of prion-contaminated MBM as a nutritional supplement in aquaculture, 2. the consumption of infected farmed fish by humans, 3. the use of feeds or other products (i.e. gelatin, milk replacers) derived from TSE-affected fish for mammalian or piscine nutrition, 4. the use of fishmeals cross-contaminated with MBM in mammalian diets, and 5. the escape of infected fish, or the release of infected waste from aquaculture facilities into the marine environment. These scenarios are depicted in Fig. 2 .
With fish mariculture turning into a very important and rich protein source for humans, consumers may become concerned about the possibility of farmed fish developing prion disease, or serving as passive carriers of prion infectivity. All farmed fish receive commercial feeds containing 40-55% protein, and since some of it is likely to be of animal origin, the possibility of feed contamination with mammalian prions cannot be excluded. Interestingly, in the late 1980s, total fish feed production in the UK was in the order of 75,000 tons per year, with the use of about 3750 tons of MBM in fish feed [104] .
However, how realistic is the thesis that fish prion proteins may misfold and form abnormal aggregates? The striking conservation of structural motifs between mammalian and piscine PrP molecules makes it rather difficult to exclude such a possibility. Regarding the convertibility potential of fish PrPs, it has been suggested that the extended type A-repeat domain in sea bream PrP-1 and other fish PrPs could confer on these proteins the ability to self-polymerize and aggregate [85] . In addition, it has been noted that motifs similar to those observed in fish PrPs can also be identified in unrelated proteins such as the piscine annexin 11 and the mammalian lectin L-29 [77] . Notably, both these proteins display self-aggregation properties, and annexin 11 is, like PrP, a neuro-specific membrane protein.
Transmission studies in commercially important fish species
At present, only a few studies have explored the experimental transmission of TSEs to teleost fish. The first attempts in this direction involved the oral and parenteral inoculation of two commercially important fish species, rainbow trout and turbot, with the 139A mouse-adapted scrapie strain [105] . Although the fish displayed no clinico-histopathological signs during the three month-experimental period, a mouse bioassay revealed that they carried residual infectivity. Specifically, mice intracranially inoculated with trout intestinal extracts one day after oral challenge were positive for brain PrP Sc Recently, we reported data on the oral transmission of BSE and scrapie to gilthead sea bream (Sparus aurata) [106] . Interestingly, at two years p.i., a number of fish that had been force-fed BSE-or scrapie-infected brain homogenates developed abnormal plaque-like deposits in their brains. Specifically, the brains of two out of five fish inoculated with scrapie developed signs of abnormal protein aggregation at 24 months p.i. These aggregates were positively stained with polyclonal antibodies raised against fish PrPs, but showed no proteinase K (PK)-resistance or Congo red birefringence (Fig. 3A) . The brains of the BSE-challenged fish, however, displayed a much more striking picture, having already developed the first signs of abnormal deposition at eight months p.i. A general progression in size, PK-resistance and morphological features was observed thereafter, resulting in an impressive number of aggregates in all the brain regions examined at 24 months p.i. Three out of five fish sacrificed at this time point showed 500-800 deposits per brain section each, 70-85% of which were PK-resistant and had a mean diameter of 30 μm. These aggregates were PAS-positive, congophilic and birefringent in polarized light, indicating an amyloid or amyloid-like fibrillar structure (Fig. 3B) . In contrast to the TSE-challenged individuals, no signs of abnormal aggregation or any other lesions were observed in the brains of the control fish "challenged" with bovine or ovine brain homogenates prepared from healthy animals. Altogether, the development of abnormal brain deposits in BSE-challenged sea bream constitutes an unprecedented histopathology in fish.
Neuropathology in TSE-challenged sea bream
The lesions observed in the brains of the BSE-infected sea bream share some remarkable similarities with those typically seen in prionaffected mammalian brains. For instance, the deposits in fish brains were only detectable where neuronal parenchyma was present, a feature greatly resembling the localization of prion amyloid plaques in mammals [107] . The most extensively affected regions included the cerebellum (which displayed a mammal-like deposition motif [108] ), the lateral nucleus of the ventral telencephalic area (a fish counterpart to the basal nucleus of Meynert in mammals [109] ), the lateral telencephalic pallium (homologue to the mammalian hippocampus [110] ), and finally the thalamus and diencephalon. Notably, no spongiosis was observed in any of the brain regions examined. However, cases of TSE subtypes that develop little or no vacuolation have also been reported for human prion diseases [111] . Interestingly, the neurodegeneration observed in BSE-challenged sea bream affected only neurites, as opposed to the "classically defined" degeneration of neuronal somata. Based on the morphological progression of the abnormal deposits and the level of neurite involvement, aggregates were classified into two main categories. "Pre-mature" deposits, observed mostly at earlier time points and consisting mainly of dystrophic neurites that have lost their coherence, appear to mark initial stages of neurodegeneration. "Mature" deposits, observed 24 months p.i., seem to result from the complete deconstruction of fibers, leading to the development of a more homogenous and flocculated extracellular material, with increased PrP-immunoreactivity, congophilia and birefringence in polarized light. The two types of aggregates in the brains of BSE-challenged sea bream could be interpreted as different stages of pathogenesis, with the former temporally preceding the latter. For scrapie-challenged sea bream, the distribution and morphology of the observed neuropathology could not be evaluated and classified as mentioned earlier, due to the limited number of fish developing abnormal deposits in this group.
Absence of "clinical symptoms" in fish: presymptomatic carrier state?
Visual examination of challenged fish throughout the post inoculation period revealed no signs of altered swimming behavior or eating habits. However, previous studies have shown that species once thought to be resistant to certain TSE strains can be life-long carriers of the infection without ever developing a clinical disease. For example, the absence of clinical symptoms has been reported in mice following the primary transmission of sheep and hamster scrapie. However, sequential passage of infectious material did result in the development of clinical disease [82] . Interestingly, differential susceptibility to specific pathogens is also known among piscine species. For instance, closely related fish species may exhibit differential resistance to viral infections, as illustrated by the development of clinical disease in sea bass but not in sea bream infected with nodavirus [112, 113] . On the other hand, the absence of clinical symptoms in BSE-challenged sea bream could be related to the remarkable ability of teleost fish to continuously produce new neurons throughout their lifetime. It is well known that adult fish can regenerate destroyed retinal tissue, optic nerve axons, and degenerated brain stem neurites, resulting in functional recovery of these structures [114, 115] . Given the fact that farmed fish remain in aquaculture facilities up to 20 months before reaching the required commercial weight, the lack of clinical disease in infected animals may become a crucial issue of unanticipated relevance for public health.
Differential susceptibility of fish species to prion infection
In a parallel study, we inoculated European sea bass (Dicentrarchus labrax) with the same infectious material, namely BSE and scrapie. Interestingly, in contrast to the sea bream, none of the challenged individuals showed any clinical symptoms or histopathological evidence of abnormal deposition at any point throughout the time course of the study. Sea bass and sea bream are both Perciformes, the largest class of teleosts. Although they belong to different families, Sparidae (sea bream) and Moronidae (sea bass), the two species are quite closely related at the phylogenetic and anatomical levels. Since the amino acid sequence of sea bass PrP is not available, it is not clear how it might differ from that of sea bream PrP. However, the two proteins display different reactivities against anti-fish PrP antibodies. Conceivably, such differences could confer on the sea bass PrP resistance to the PrP Sc in the inoculum, and thus, reinforce the "transmission barrier" in these experiments.
Another factor possibly involved in the different reaction of the two species to prion inoculation might be the ease with which exogenous PrP Sc can cross the intestinal barrier and reach the CNS [116] . In teleosts, like in other vertebrates, oral pathogens are initially confronted by activated immune cells on the enteric wall. Macrophages, whose efficiency contributes to the resistance against pathogens, play an important role in this process. While in sea bass, enteric phagocytes seem to become extensively activated upon microbial attack [117] , it has been reported that the intestinal mucosa of the sea bream may be relatively permissive to infection by certain bacteria [118] . Although plausible, these hypotheses do not entirely explain the differential sensitivity of the two species to prion infection, since cases of pathogenesis in which the clinically affected species is the sea bass and not the sea bream are also known [112] . It is noteworthy, however, that the different susceptibility of the two species can be regarded as an internal control in our transmission experiments. Specifically, the fact that despite the close relationship between the two species, only sea bream were affected, strengthens the hypothesis that the observed neuropathology represents a novel piscine amyloidosis triggered by mammalian prions. Thus, transmissibility of prions to fish exhibits species specificity, a common feature of TSEs.
Possible routes of neuroinvasion: tissues harboring infectivity
Immunohistochemical examination of peripheral tissues from TSEinoculated sea bream including spleen and intestine revealed no signs of abnormal protein accumulation at any of the time points tested. Therefore, it is likely that the transit of prions from the fish gastrointestinal (GI) tract to the CNS might have occurred long before the first time point of sacrifice, perhaps only a few hours or days after oral challenge, leaving no trace of infectivity in the peripheral tissues tested thereafter. Transmission studies in rainbow trout and turbot have shown that specific binding of exogenous PrP Sc (139A scrapie strain) can be detected in the intestinal mucosa for up to seven days p.i., despite the absence of active uptake by the epithelial cells [105, 119] . Preliminary data from a more recent study demonstrate the importance of residual infectivity, suggesting that after oral challenge with the ME7 mouse-adapted scrapie, prions can cross the intestinal wall of the sea bream and be delivered from the peritoneal cavity into the spleen (Figueras et al., unpublished data) . More specifically, inoculated fish were sacrificed at regular time points, and various tissues, including spleen and intestine, were used to intracranially inoculate mice (Fig. 3C) . The TSE-challenged fish never showed histopathological or clinical symptoms throughout the 18 monthexperimental period. However, serial passage to mice of tissues from fish sacrificed one week p.i. induced vacuolation in the brains of some of the mice, 300 days after the intracranial inoculation. Concretely, spongiosis without clinical disease was detected in five out of 19 recipient mice inoculated with scrapie-infected fish spleens, and in 12 out of 17 individuals challenged with scrapie-infected fish intestines. These findings suggest, on one hand, that the TSE agent might have been able to reach the fish brain in a remarkably short period of time, either after peripheral propagation or even by direct neuroinvasion. On the other hand, this study emphasizes the need for a thorough examination of peripheral tissues in asymptomatic individuals following prion inoculation.
There is no doubt that the intestine represents the main entry point for oral pathogens. In zebrafish, for example, it has been proposed that the GI tract may serve as a potential portal for exogenous PrP Sc , due to the high PrP mRNA levels detected in the posterior intestine of zebrafish larvae [68] . In mammals, studies have shown that the pathogenic agent may invade the CNS directly, by exploiting the extended autonomous intestinal innervation [120] . In particular, it has been proposed that BSE neuroinvasion may take place via the parasympathetic nerve fibers of the vagus nerve into the brain stem of orally-challenged cattle [81] . Such a route of dispersion requires the adequate expression of endogenous PrP C within the peripheral nervous system [121] . In the sea bream, immunohistochemical examination of intestinal tissue revealed three main regions of intense PrP-immunopositivity, namely the serosa, the myenteric plexus (corresponding to Auerbach's plexus in mammals) and the submucous plexus (a homologue to mammalian Meissner's plexus). Both the myenteric and the submucous plexus contain many parasympathetic nerves and ganglia, one of which is a nucleus of the vagus nerve running to the medulla oblongata in the brain stem of mammals and teleosts. The hypothesis that the infectious agent might use the enteric nervous system to invade the fish CNS is supported by the progressive changes observed in the regional distribution of abnormal deposits in sea bream brain [81] . Initially, the region affected is the posterior part of the brain, with the brain stem displaying the most severe lesion profile. Subsequently, anterior anatomical regions show signs of abnormal aggregation as well, although posterior brain areas continue to be affected. Interestingly, it has been proposed that direct neuroinvasion of the infectious agent following per os challenge might be related to the absence of clinical symptoms and the reduced attack rate of the transmitted disease [122] , an observation that is in agreement with the asymptomatic amyloidosis developed by BSE-challenged sea bream.
Future directions
Monitoring for infectious neurodegenerative disease in farmed fish
The rapid worldwide expansion of fish farming calls for the implementation of efficient measures to ensure animal health and food safety. The fact that pathogens can spread considerably more easily through flowing water than between land animals is one of the main difficulties when dealing with aquatic diseases. Over the last years, the aquaculture industry has been faced with an increasing number of infectious diseases affecting both farmed and feral populations. Surveillance and monitoring programs have therefore been developed in many countries, in an attempt to prevent and control the emergence of new fish pathologies [123] . The list of notifiable diseases varies depending on the specific needs of each region. In Europe, all countries are asked to comply with the Council Directive (2006/88/EC) on health requirements for aquaculture animals. Nevertheless, it would be sensible to enrich the list of large-scale spot checks in fish farms by including the histological examination of fish brains, in order to detect possible signs of feed-induced or even spontaneous PrP Sc amyloidosis.
As described earlier, BSE-infected sea bream developed the first signs of abnormal aggregation already at eight months p.i., a time period that lies within the grow-out phase of fish breeding. Moreover, the fact that these animals remained asymptomatic throughout the experimental period raises the possibility that affected fish may generally go undetected before ending up on our plates.
Further transmission studies in commercially important fish species
Gilthead sea bream and European sea bass are the two most important farmed fish in the Mediterranean Sea, with the main producers being Greece, Turkey, Spain, France and Italy. In 2004, the annual production levels of both species reached 160,000 tons worldwide. Therefore, assessing the risk of TSE transmission to these fish is an issue of major importance for public health. On a global scale, the practice of aquaculture is experiencing steady growth rates, driven by the increasing demand for aquatic food products. According to projections by the Food and Agriculture Organization of the United Nations (FAO), the global production of farmed fish will have to reach 80 million tons by 2050, in order to maintain the current level of fish consumption per capita. Amazingly, not all countries have introduced laws to regulate the use of rendered mammalian proteins for fish nutrition and, in some cases, those that have, have incurred in minor and major violations [124] . Hence, the likelihood that contaminated MBMs might have been inadvertently fed to farmed fish is considerably high. In this regard, the amyloidosis observed in the brains of BSE-fed sea bream demonstrates that certain fish species can develop neuropathology following ingestion of prion-contaminated meals. Therefore, further transmission studies with other commercially important fish species, including salmon (Salmo salar), trout (Oncorhynchus mykiss), and carp (Cyprinus carpio) should be conducted in order to evaluate the likelihood of acquiring TSEs upon consumption of infected feeds (Fig. 4) . In addition, primary TSE transmission studies in piscine species that are considered future candidates for mariculture would be advisable, especially those closely related to sea bream, such as the common dentex (Dentex dentex, Sparidae) and the red porgy (Pagrus pagrus, Sparidae).
Zebrafish as a model for prion pathobiology
Clearly, transmission experiments in commercially important species are necessary to directly assess the risk that TSE-infected fish would pose to humans. On the other hand, addressing the cellular and molecular aspects of prion transmission to fish requires the use of established model organisms. The zebrafish is best fitted for this purpose, not only because of its well-characterized neuroanatomy and neural development, but also because of the availability of useful research tools, such as mutant strains, GFP-transgenic lines, specific antibodies, cell lines and a fully sequenced genome. Additionally, zebrafish larvae are optimally suited for the study of neurological diseases because they display quantifiable neuropathological and behavioral phenotypes similar to those observed in humans [125] . It would be particularly interesting to know whether scrapie or CJD prions can be efficiently inoculated to transgenic zebrafish expressing mouse or human PrPs. Similarly, expression of pathogenic PrP mutants in wildtype and transgenic fish could be of great value in elucidating the genetic basis of prion disease. Engineering of these animals, currently underway, will provide an ideal tool to systematically analyze prion replication in fish brains, as well as the development of PrP aggregates, brain lesions, and possibly clinical disease. Another fascinating perspective is the possibility to study the effect of exogenously added prions on zebrafish embryos. Such experiments could significantly facilitate the analysis of PrP C and PrP Sc behavior in vivo, thus contributing valuable insights into the relationship between prion conversion and PrP dysfunction. Altogether, transmission experiments in zebrafish could help to effectively evaluate the susceptibility of fish to TSEs, as well as the mechanistic link between PrP function and prion pathogenesis. 
Assessing transmissibility and convertibility
Issues of prion transmissibility between fish and mammals need to be given full consideration because of the possibility that fish fed with prion-contaminated MBM may further transmit TSEs through the food chain. To evaluate this scenario, secondary transmission experiments between BSE-affected fish brains and mice carrying the bovine Prnp gene are currently underway. Further studies in transgenic fish will also help assess the risk of potential transmission of piscine amyloidoses to mammals or to other fish species (Fig. 4) . For instance, the use of transgenic zebrafish carrying the bovine Prnp, or mice carrying the gene coding for fish PrP on a PrP knockout background would answer a plethora of questions concerning not only host-related pathogenic determinants but also the specific conditions required for certain intra-species transmissions.
The discovery of residual prion infectivity in fish intestines and spleens is also a matter of great concern, as it suggests that even fish species resistant to prion infection might harbor infectivity shortly after ingestion of contaminated meals, thus being able to transmit the disease to consumers. Similar studies should be undertaken employing a variety of fish species and TSE strains, including atypical scrapie and BSE, to assess residual infectivity levels not only in spleen and intestine, but also in blood and other "high risk" tissues (Fig. 4) . Furthermore, bioassays should also include "humanized" mice in order to directly assess the risk of transmission to humans.
Another basic question that requires further clarification is the convertibility potential of fish PrPs. Ongoing experiments using the sensitive protein misfolding cyclic amplification (PMCA) method [126, 127] may reveal whether piscine PrPs have the intrinsic ability to misfold and aggregate. In addition, the use of TSE-infected cell lines could become an important tool to investigate possible molecular interactions between mammalian PrP Sc and fish PrP C , leading to the conversion of piscine PrPs. Aside from transmissibility and convertibility issues, the composition of the deposits found in the brains of the BSE-challenged sea bream deserves further examination. Concretely, the identification of other aggregated molecules in brain deposits could help define the properties of these novel amyloid plaques, and perhaps their mechanistic connection to neurodegeneration. For instance, previous data on the composition of amyloid deposits present in degenerating neuronal tissue have suggested that the components of such aggregates may represent the outcome of the degeneration process rather than the cause of neuronal cell death [128] . Thus, the study of novel proteinaceous deposits may contribute new leads to the debate about the causal link between neurotoxicity and protein oligomerization.
Dissecting the physiological roles of PrP in the zebrafish
The molecular basis of prion disease is closely associated with the structural and functional properties of PrP. Therefore, deep understanding of prion pathogenesis in fish and mammals cannot be reached without basic knowledge about the physiological roles of PrP. The knockdown phenotypes described in zebrafish constitute the first experimental evidence that the lack of PrP can cause dramatic abnormalities in a whole organism [92] . In addition, the finding that PrPs regulate cell-cell communication via known cellular pathways provides an ideal opportunity to establish how PrP may exert its proposed neuroprotective role (Fig. 5) . It is noteworthy that some of the molecules affected in PrP-1 knockdown embryos (Src-kinases, Ecadherin, β-catenin, etc.) are not only essential for early zebrafish development but also play important roles in neuronal function and during neurodegeneration [96] . Therefore, it will be crucial to further characterize the signaling pathways under the control of PrP-1 using biochemical, cell biological, proteomic and imaging tools. Such experiments are currently being carried out in fish embryos and embryonic stem cells. Ideally, this basic knowledge should be integrated into the design and interpretation of studies addressing the function of PrP in mammalian cells, as well the experimental transmission of prion disease between fish and mammals.
Characterization of the PrP-2 knockdown phenotype is currently in progress. Preliminary results show that PrP-2 is required for the proliferation and differentiation of different groups of embryonic neurons (Málaga-Trillo and Luncz, unpublished data). A similar phenotype has been reported for PrP knockout mice [41] , although the defect does not impair neural development to the extent seen in the zebrafish [92] . Because PrP-2 also shares the ability to elicit cellcell adhesion and intracellular signaling, it is likely to regulate neural development via the same molecular pathways controlled by PrP-1 in the early gastrula. Thus, morphological and molecular analyses of the PrP-2 phenotype may provide valuable mechanistic insights into the roles of PrP during neuronal differentiation, axon growth, and synaptogenesis. Integrating the emerging zebrafish data within the vast amount of information available from mammalian cells and knockout mice promises to become a lengthy but rewarding task.
Concluding remarks
For many years, prion researchers have relied heavily on the use of mammalian models as experimental systems. This strategy, and particularly the development of genetically modified mice, has led to outstanding discoveries in the field. At the same time, the experimental difficulties associated with the study of TSEs have exposed the need for new animal models in prion biology. Recently, researchers have explored the utility of fish to address questions concerning the physiological roles of PrP and the risk of TSEs in these organisms. An interesting picture has emerged, suggesting that transmission of prions could potentially take place between commercially important fish and mammals, although the implications of these findings for human and animal health remain to be clarified. Much remains to be done in order to confirm or rule out the existence of bona fide prions in fish. Nevertheless, the use of fish models in TSE research will likely uncover novel aspects of prion transmission across a wide range of hosts, relevant to human health. In addition, the finding that fish and mammalian PrPs share important roles in cellcell communication might help elucidate the molecular mechanisms by which prions induce neuronal death, setting the stage for the identification of new anti-prion therapeutic targets.
